Suzetrigine is named as a drug or biological intervention in 4 clinical trials in our USA trial register, 3 of which are recruiting. The lead sponsor is Vertex Pharmaceuticals Incorporated. Registered phases: Phase 3 and Phase 4. Conditions studied include Diabetic Peripheral Neuropathic Pain; Pain.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07538570 | Evaluation of Pain Treatment After Total Knee Arthroplasty Pain |
Phase 4 | Recruiting |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathic Pain |
Phase 3 | Recruiting |
| NCT07231419 | Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathic Pain |
Phase 3 | Recruiting |
| NCT06696443 | Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) (ClinicalTrials.gov ↗) Diabetic Peripheral Neuropathic Pain |
Phase 3 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Diabetic Peripheral Neuropathic Pain | 3 |
| Pain | 1 |
| Lead sponsor | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 4 |
| Register | Suzetrigine trials |
|---|---|
| Clinical trials in USA | 4 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Suzetrigine works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Suzetrigine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.